Amedisys Stock Odds of Future Stock Price Finishing Over 194.0

AMED Stock  USD 92.46  0.17  0.18%   
Amedisys' implied volatility is one of the determining factors in the pricing options written on Amedisys. Implied volatility approximates the future value of Amedisys based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Amedisys over a specific time period. For example, 2024-04-19 CALL at $90.0 is a CALL option contract on Amedisys' common stock with a strick price of 90.0 expiring on 2024-04-19. The contract was not traded in recent days and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $1.0, and an ask price of $5.9. The implied volatility as of the 28th of March is 19.52. View All Amedisys options

Closest to current price Amedisys long CALL Option Payoff at Expiration

Amedisys' future price is the expected price of Amedisys instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Amedisys performance during a given time horizon utilizing its historical volatility. Check out Amedisys Backtesting, Amedisys Valuation, Amedisys Correlation, Amedisys Hype Analysis, Amedisys Volatility, Amedisys History as well as Amedisys Performance.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
  
At present, Amedisys' Price To Operating Cash Flows Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 26.14, whereas Price To Sales Ratio is forecasted to decline to 0.86. Please specify Amedisys' target price for which you would like Amedisys odds to be computed.

Amedisys Target Price Odds to finish over 194.0

The tendency of Amedisys Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 194.00  or more in 90 days
 92.46 90 days 194.00 
close to zero percent
Based on a normal probability distribution, the odds of Amedisys to move over $ 194.00  or more in 90 days from now is close to zero percent (This Amedisys probability density function shows the probability of Amedisys Stock to fall within a particular range of prices over 90 days) . Probability of Amedisys price to stay between its current price of $ 92.46  and $ 194.00  at the end of the 90-day period is under 95 .
Given the investment horizon of 90 days Amedisys has a beta of -0.19. This suggests as returns on benchmark increase, returns on holding Amedisys are expected to decrease at a much lower rate. During the bear market, however, Amedisys is likely to outperform the market. Additionally Amedisys has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Amedisys Price Density   
       Price  

Predictive Modules for Amedisys

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amedisys. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
92.0192.4492.87
Details
Intrinsic
Valuation
LowRealHigh
90.4390.86101.71
Details
Naive
Forecast
LowNextHigh
91.2991.7392.16
Details
10 Analysts
Consensus
LowTargetHigh
87.4596.10106.67
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amedisys. Your research has to be compared to or analyzed against Amedisys' peers to derive any actionable benefits. When done correctly, Amedisys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amedisys.

Amedisys Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Amedisys is not an exception. The market had few large corrections towards the Amedisys' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amedisys, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amedisys within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.03
β
Beta against NYSE Composite-0.19
σ
Overall volatility
0.91
Ir
Information ratio -0.42

Amedisys Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amedisys for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amedisys can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Amedisys generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.24 B. Net Loss for the year was (9.75 M) with profit before overhead, payroll, taxes, and interest of 453.98 M.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from investing.com: RBC raises Amedisys stock PT to 100 on AMED deal completion confidence

Amedisys Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amedisys Stock often depends not only on the future outlook of the current and potential Amedisys' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amedisys' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32.6 M
Cash And Short Term Investments145.9 M

Amedisys Technical Analysis

Amedisys' future price can be derived by breaking down and analyzing its technical indicators over time. Amedisys Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Amedisys. In general, you should focus on analyzing Amedisys Stock price patterns and their correlations with different microeconomic environments and drivers.

Amedisys Predictive Forecast Models

Amedisys' time-series forecasting models is one of many Amedisys' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Amedisys' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Amedisys

Checking the ongoing alerts about Amedisys for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Amedisys help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Amedisys generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.24 B. Net Loss for the year was (9.75 M) with profit before overhead, payroll, taxes, and interest of 453.98 M.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from investing.com: RBC raises Amedisys stock PT to 100 on AMED deal completion confidence
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Amedisys Backtesting, Amedisys Valuation, Amedisys Correlation, Amedisys Hype Analysis, Amedisys Volatility, Amedisys History as well as Amedisys Performance.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.30)
Revenue Per Share
68.603
Quarterly Revenue Growth
0.016
Return On Assets
0.0598
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.